The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Prostaglandins

• Publication date

  1984-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0090-6980(84)90083-2PMID 6326201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.

  1983cited by this paper
• THE BINDING OF [3H]‐PROSTACYCLIN TO MEMBRANES OF A NEURONAL SOMATIC HYBRID

  1981cited by this paper
• Characteristics of the β 1- and β 2-adrenergic-sensitive adenylate cyclases in glial cell primary cultures and their comparison with β 2-adrenergic-sensitive adenylate cyclase of meningeal cells

  1981cited by this paper
• Characteristics of the beta 1-and beta 2-adrenergic-sensitive adenylate cyclases in glial cell primary cultures and their comparison with beta 2-adrenergic-sensitive adenylate cyclase of meningeal cells.

  1981cited by this paper
• Prostaglandin I2 receptors in a particulate fraction of platelets of various species.

  1980cited by this paper
• Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.

  1979cited by this paper
• Selective binding site for [3H]prostacyclin on platelets.

  1979cited by this paper
• Identification of platelet receptors for prostaglandin I2 and D2.

  1979cited by this paper
• Effects of prostacyclin and a stable analogue, 6β-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs

  1979cited by this paper
• Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.

  1978cited by this paper
• The relative activity of prostacyclin (PGI2) and a stable analogue 6β‐PGI1 on the gastrointestinal and cardiovascular systems

  1978cited by this paper
• Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha.

  1977cited by this paper
• Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.

  1977cited by this paper
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX).

  1977cited by this paper
• The chemical structure of prostaglandin X (prostacyclin).

  1976cited by this paper
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

  1976cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper

• Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension

  2022cites this paper
• Gradient-dependent inhibition of stimulatory signaling from platelet G protein-coupled receptors

  2019cites this paper
• Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.

  2012cites this paper
• Índice / Index

  2010cites this paper
• DP Prostanoid Receptor

  2008cites this paper
• Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects.

  2002cites this paper
• Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: comparison of antithrombotic and hemodynamic effects.

  2000cites this paper
• Expression of Prostacyclin Receptors in Luteinizing Hormone-Releasing Hormone Immortalized Neurons: Role in the Control of Hormone Secretion* *This work was supported by funds from Telethon (Grant E.523), by CNR through the Project Aging (95.01020PF40), and by MURST.

  1999cites this paper
• Expression of prostacyclin receptors in luteinizing hormone-releasing hormone immortalized neurons: role in the control of hormone secretion.

  1999cites this paper
• Prostacyclin and Its Receptors

  1999cites this paper
• Internalization and down-regulation of the prostacyclin receptor in human platelets.

  1997cites this paper
• Induction of human thioredoxin in cultured human retinal pigment epithelial cells through cyclic AMP-dependent pathway; involvement in the cytoprotective activity of prostaglandin E1.

  1997cites this paper
• Platelet Arachidonic Acid Metabolism and Eicosanoid Receptors

  1997cites this paper
• Platelet prostanoid receptors.

  1996cites this paper
• Binding affinities of isocarbacyclin methyl ester and its free acid to prostanoid receptors.

  1995cites this paper
• International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

  1994cites this paper
• VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes

  1994cites this paper
• Prostanoid receptors and their biological actions.

  1993cites this paper
• Disordered eicosanoid formation in pregnancy-induced hypertension.

  1993cites this paper
• Two types of prostacyclin receptor coupling to stimulation of adenylate cyclase and phosphatidylinositol hydrolysis in a cultured mast cell line, BNu-2cl3 cells.

  1993cites this paper
• Non-serotonergic 3H-ketanserin binding sites in human platelets: characteristics and interaction with calcium antagonists.

  1992cites this paper
• Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.

  1992cites this paper
• Translocation of alpha subunits of stimulatory guanine nucleotide-binding proteins through stimulation of the prostacyclin receptor in mouse mastocytoma cells.

  1992cites this paper
• Cytoprotection by iloprost against paracetamol‐induced toxicity in hamster isolated hepatocytes

  1992cites this paper
• Eicosanoids in atherosclerosis.

  1991cites this paper
• Role of endothelium in responses of isolated hepatic vessels to vasoactive agents.

  1991cites this paper
• Pharmacological receptors on blood platelets.

  1991cites this paper
• Identification of a prostacyclin receptor coupled to the adenylate cyclase system via a stimulatory GTP-binding protein in mouse mastocytoma P-815 cells.

  1990cites this paper
• Mode of action of PGI2 and of its stable derivative iloprost on platelets and leukocytes.

  1990cites this paper
• Cellular distribution of prostacyclin synthase and specific prostacyclin binding sites in bovine corpora lutea of pregnancy.

  1990cites this paper
• Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.

  1990cites this paper
• Intraluteal infusions of prostaglandins of the E, D, I, and A series prevent PGF2 alpha-induced, but not spontaneous, luteal regression in rhesus monkeys.

  1990cites this paper
• Disparate effects of the prostaglandin synthesis inhibitors, meclofenamate, and flurbiprofen on monkey luteal tissue in vitro.

  1990cites this paper
• [Prostaglandin interaction in the human liver].

  1989cites this paper
• Decrease of the prostaglandin I2 binding capacity in thyroids from patients with Graves' disease.

  1989cites this paper
• The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase

  1989cites this paper
• Iloprost binding and inhibition of aggregation in platelet rich plasma. Differences between normal and type IIa hypercholesterolemic subjects.

  1989cites this paper
• The presence of prostacyclin binding sites in nonpregnant bovine uterine tissue.

  1989cites this paper
• Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.

  1989cites this paper
• Prostaglandin-Interaktion in der menschlichen Leber

  1989influential citation
• The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue.

  1988cites this paper
• Protective Effects of a Platelet Activating Factor (PAF) Antagonist and Its Combined Treatment with Prostaglandin (PG) E1 in Traumatic Shock

  1988cites this paper
• [Synthesis of tritium-labelled prostaglandin E1 and its binding to human platelets].

  1988cites this paper
• Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.

  1988cites this paper
• Platelet and vessel associated prostacyclin and thromboxane A2/prostaglandin endoperoxide receptors

  1988cites this paper
• Binding to prostaglandin (PG) receptors and activation of adenyl cyclase by 20-isopropylidene-PGS in rabbit platelet membranes.

  1988cites this paper
• Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung.

  1988cites this paper
• (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.

  1988cites this paper
• PGI2-receptors and molecular mechanisms in platelets and vasculature: state of the art.

  1987cites this paper
• (5Z)‐carbacyclin discriminates between prostacyclin‐receptors coupled to adenylate cyclase in vascular smooth muscle and platelets

  1987cites this paper
• The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.

  1987cites this paper
• Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.

  1987cites this paper
• Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.

  1986cites this paper
• Characterization and regulation of prostaglandin and leukotriene receptors: an overview.

  1986cites this paper
• Differential effects of in vitro ethanol on prostaglandin E1-sensitive adenylate cyclase from smooth muscle cells and platelets.

  1985cites this paper
• Binding of 3H-iloprost to rat gastric mucosa: a pitfall in performing radioligand binding assays.

  1985cites this paper
• Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors

  1985cites this paper
• Receptors and mechanisms of action of prostacyclin in preserving non-mucosal cell integrity.

  1985cites this paper
• Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.

  1985cites this paper
• 8 – Platelet Eicosanoid Receptors

  1985cites this paper
• Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.

  1985cites this paper
• 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.

  1984cites this paper
• The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells

  1984cites this paper
• Antithrombotic assessment and clinical potential of prostacyclin analogues.

  1984cites this paper
• Prostacyclin-sensitive adenylate cyclase in cultured myocytes: differences between rabbit aorta and mesenteric artery.

  1984cites this paper